ACC, Novo Nordisk launch program to improve type 2 diabetes care
Click Here to Manage Email Alerts
The American College of Cardiology and Novo Nordisk announced they have begun a program to help improve multidisciplinary care for patients with type 2 diabetes.
The global UNITE (Multidisciplinary Teams in Cardiometabolic Care) program will provide education and tools to clinicians across specialties to enable an integrated approach for care of type 2 diabetes and CVD, according to a press release issued by the ACC.
“Despite advances in care, people with type 2 diabetes continue to face a higher risk of death and disability from cardiovascular disease,” ACC President Athena Poppas, MD, FACC, director of the Lifespan Cardiovascular Institute in Providence, Rhode Island, and chief of cardiology and professor of medicine at the Warren Alpert School of Medicine at Brown University, said in the release. “New strategies for managing this complex disease are needed. Through UNITE, we’re meeting that need by providing guidance and tools that can be easily integrated into day-to-day clinical practice to optimize cardiovascular risk through treatment pathways and collaborative management of comorbidities.”
The program may help clinicians implement the recommendations of the ACC’s expert consensus decision pathway on managing CV risk in type 2 diabetes, published in August, according to the release.
The program will include educational webinars on cardiometabolics, cardiometabolic education modules for those managing CV care and a live cardiometabolic clinic, according to the release.
In September, the ACC and Novo Nordisk launched an initiative to promote CV risk reduction in patients with type 2 diabetes.
Collapse
Read more about
Click Here to Manage Email Alerts